PTD-hFOXP3 protein acts as an immune regulator to convert human CD4 +CD25- T cells to regulatory T-like cells

Journal of Cellular Biochemistry

Volumn 113, Issue 12, 2012, Pages 3797-3809

  Liu, Xia ^a   Xu, Xun ^a,b   Lin, Xin ^a   Tian, Yuxiang ^a   Ji, Baoju ^a   Xia, Sheng ^a   Xu, Sanrong ^a   Yin, Qing ^a   Zhang, Miaomiao ^a   Jiao, Zhijun ^a   Wang, Shengjun ^a   Xu, Huaxi ^a   Shao, Qixiang ^a  

^a JIANGSU UNIVERSITY   (China)

^b INSTITUTE OF MATERIALS RESEARCH   (Germany)

Author keywords

CYTOKINES; PROLIFERATION; PTD HFOXP3; REGULATORY T CELLS; TREG LIKE CELLS

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; PROTEIN TRANSDUCTION DOMAIN TRANSCRIPTION FACTOR FOXP3; T LYMPHOCYTE RECEPTOR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 84867495893     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24255     Document Type: Article

References (52)

1. Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, Orban PC, Ziegler SF, Roncarolo MG, Levings MK,. 2005. The role of 2 FOXP3 isoforms in the generation of human CD4 ± Tregs. J Clin Invest 115: 3276-3284.
2. Allan SE, Song-Zhao GX, Abraham T, McMurchy AN, Levings MK,. 2008. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 38: 3282-3289.
3. Bardel E, Larousserie F, Charlot-Rabiega P, Coulomb-L'Hermine A, Devergne O,. 2008. Human CD4 ± CD25 ± Foxp3 ± regulatory T cells do not constitutively express IL-35. J Immunol 181: 6898-6905.
4. Baum C, Schambach A,. 2011. Promoter competition for gene therapy of SCID-X1. Hum Gene Ther 22: 255-256.
5. Bennett CL, Brunkow ME, Ramsdell F, O'Briant KC, Zhu Q, Fuleihan RL, Shigeoka AO, Ochs HD, Chance PF,. 2001. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA- > AAUGAA) leads to the IPEX syndrome. Immunogenetics 53: 435-439.
6. Bettelli E, Dastrange M, Oukka M,. 2005. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 102: 5138-5143.
7. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F,. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27: 68-73.
8. Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P, McGlave PB, Blazar BR, Wagner JE,. 2011. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics. Blood 117: 1061-1070.
9. Cavazzana-Calvo M, Thrasher A, Mavilio F,. 2004. The future of gene therapy. Nature 427: 779-781.
10. Chae WJ, Henegariu O, Lee SK, Bothwell AL,. 2006. The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc Natl Acad Sci USA 103: 9631-9636.
11. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM,. 2000. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106: R75-R81.
12. Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA,. 2011. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 186: 6661-6666.
13. Chen C, Rowell EA, Thomas RM, Hancock WW, Wells AD,. 2006. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J Biol Chem 281: 36828-36834.
14. Chen LC, Delgado JC, Jensen PE, Chen X,. 2009. Direct expansion of human allospecific FoxP3 ± CD4 ± regulatory T cells with allogeneic B cells for therapeutic application. J Immunol 183: 4094-4102.
15. Choi JM, Shin JH, Sohn MH, Harding MJ, Park JH, Tobiasova Z, Kim DY, Maher SE, Chae WJ, Park SH, Lee CG, Lee SK, Bothwell AL,. 2010. Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. Proc Natl Acad Sci USA 107: 18575-18580.
16. Ciccone DN, Morshead KB, Oettinger MA,. 2004. Chromatin immunoprecipitation in the analysis of large chromatin domains across murine antigen receptor loci. Methods Enzymol 376: 334-348.
17. Cretney E, Xin A, Shi W, Minnich M, Masson F, Miasari M, Belz GT, Smyth GK, Busslinger M, Nutt SL, Kallies A,. 2011. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol 12: 304-311.
18. Di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, Bonifacio E, Del Papa B, Zei T, Ostini RI, Cecchini D, Aloisi T, Perruccio K, Ruggeri L, Balucani C, Pierini A, Sportoletti P, Aristei C, Falini B, Reisner Y, Velardi A, Aversa F, Martelli MF,. 2011. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117: 3921-3928.
19. Doeppner TR, Dietz GP, El Aanbouri M, Gerber J, Witte OW, Bahr M, Weise J,. 2009. TAT-Bcl-x(L) improves survival of neuronal precursor cells in the lesioned striatum after focal cerebral ischemia. Neurobiol Dis 34: 87-94.
20. Edinger M, Hoffmann P,. 2011. Regulatory T cells in stem cell transplantation: Strategies and first clinical experiences. Curr Opin Immunol 23: 679-684.
21. Esensten JH, Wofsy D, Bluestone JA,. 2009. Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol 5: 560-565.
22. Fontenot JD, Gavin MA, Rudensky AY,. 2003. Foxp3 programs the development and function of CD4 ± CD25 ± regulatory T cells. Nat Immunol 4: 330-336.
23. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M,. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
24. Haribhai D, Williams JB, Jia S, Nickerson D, Schmitt EG, Edwards B, Ziegelbauer J, Yassai M, Li SH, Relland LM, Wise PM, Chen A, Zheng YQ, Simpson PM, Gorski J, Salzman NH, Hessner MJ, Chatila TA, Williams CB,. 2011. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 35: 109-122.
25. Herzog RW,. 2010. Gene therapy for SCID-X1: Round 2. Mol Ther 18: 1891.
26. Hori S, Nomura T, Sakaguchi S,. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
27. Kawamoto K, Pahuja A, Nettles A, Honkanen-Scott M, Bansal-Pakala P,. 2012. Downregulation of TGF-betaRII in T effector cells leads to increased resistance to TGF-beta-mediated suppression of autoimmune responses in type I diabetes. Autoimmunity 45: 310-319.
28. Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I,. 2008. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112: 2340-2352.
29. Li B, Samanta A, Song X, Iacono KT, Brennan P, Chatila TA, Roncador G, Banham AH, Riley JL, Wang Q, Shen Y, Saouaf SJ, Greene MI,. 2007. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int Immunol 19: 825-835.
30. Lopes JE, Torgerson TR, Schubert LA, Anover SD, Ocheltree EL, Ochs HD, Ziegler SF,. 2006. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol 177: 3133-3142.
31. Nandakumar S, Miller CW, Kumaraguru U,. 2009. T regulatory cells: An overview and intervention techniques to modulate allergy outcome. Clin Mol Allergy 7: 5.
32. Ochs HD, Oukka M, Torgerson TR,. 2009. TH17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol 123: 977-983; quiz 984-985.
33. Ohkusu-Tsukada K, Toda M, Udono H, Kawakami Y, Takahashi K,. 2010. Targeted inhibition of IL-10-secreting CD25- Treg via p38 MAPK suppression in cancer immunotherapy. Eur J Immunol 40: 1011-1021.
34. Radhakrishnan S, Cabrera R, Schenk EL, Nava-Parada P, Bell MP, Van Keulen VP, Marler RJ, Felts SJ, Pease LR,. 2008. Reprogrammed FoxP3 ± T regulatory cells become IL-17 ± antigen-specific autoimmune effectors in vitro and in vivo. J Immunol 181: 3137-3147.
35. Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH,. 2002. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med 195: 1003-1012.
36. Ryu J, Han K, Park J, Choi SY,. 2003. Enhanced uptake of a heterologous protein with an HIV-1 Tat protein transduction domains (PTD) at both termini. Mol Cells 16: 385-391.
37. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M,. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
38. Schreiber E, Matthias P, Muller MM, Schaffner W,. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 17: 6419.
39. Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF,. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 276: 37672-37679.
40. Schwarze SR, Hruska KA, Dowdy SF,. 2000. Protein transduction: Unrestricted delivery into all cells ? Trends Cell Biol 10: 290-295.
41. Stock K, Nolden L, Edenhofer F, Quandel T, Brustle O,. 2010. Transcription factor-based modulation of neural stem cell differentiation using direct protein transduction. Cell Mol Life Sci 67: 2439-2449.
42. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM,. 1998. CD4 ± CD25 ± T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160: 1212-1218.
43. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL,. 2010. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS ONE 5: e11469.
44. Torgerson TR, Genin A, Chen C, Zhang M, Zhou B, Anover-Sombke S, Frank MB, Dozmorov I, Ocheltree E, Kulmala P, Centola M, Ochs HD, Wells AD, Cron RQ,. 2009. FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression. J Immunol 183: 907-915.
45. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA,. 2004. Loss of functional suppression by CD4 ± CD25 ± regulatory T cells in patients with multiple sclerosis. J Exp Med 199: 971-979.
46. Vives E, Brodin P, Lebleu B,. 1997. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272: 16010-16017.
47. Wahl SM, Swisher J, McCartney-Francis N, Chen W,. 2004. TGF-beta: The perpetrator of immune suppression by regulatory T cells and suicidal T cells. J Leukoc Biol 76: 15-24.
48. Wright GP, Ehrenstein MR, Stauss HJ,. 2011. Regulatory T-cell adoptive immunotherapy: Potential for treatment of autoimmunity. Expert Rev Clin Immunol 7: 213-225.
49. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, Bates DL, Guo L, Han A, Ziegler SF, Mathis D, Benoist C, Chen L, Rao A,. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387.
50. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, Maeda M, Onodera M, Uchiyama T, Fujii S, Sakaguchi S,. 2004. Crucial role of FOXP3 in the development and function of human CD25 ± CD4 ± regulatory T cells. Int Immunol 16: 1643-1656.
51. Yan B, Liu Y,. 2009. The nature of increased circulating CD4CD25Foxp3 T cells in patients with systemic lupus erythematosus: A novel hypothesis. Open Rheumatol J 3: 22-24.
52. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY,. 2007. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445: 936-940.